2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane

C128H180F2N12O19 — CID 163961586

IUPAC2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane
SMILESC.COc1cc(CCCCO[C@@H]2CCN(C(C(=O)O)c3cc(C)ccc3C3CCC(C)(C)CO3)C2)nc2c1CCCN2.COc1cc(CCCCO[C@@H]2CCN(C(C(=O)O)c3cc(C)ccc3C3CCC(F)(F)CO3)C2)nc2c1CCCN2.Cc1ccc(C2CCC(C)(C)CO2)c(C(C(=O)O)N2CC[C@@H](OCCCCc3ccc4c(n3)NCCC4)C2)c1.Cc1ccc(C2COC(C)(C)CO2)c(C(C(=O)O)N2CC[C@@H](OCCCCc3ccc4c(n3)NCCC4)C2)c1
InChIInChI=1S/C33H47N3O5.C32H45N3O4.C31H41F2N3O5.C31H43N3O5.CH4/c1-22-10-11-25(28-12-14-33(2,3)21-41-28)27(18-22)30(32(37)38)36-16-13-24(20-36)40-17-6-5-8-23-19-29(39-4)26-9-7-15-34-31(26)35-23;1-22-9-12-26(28-13-15-32(2,3)21-39-28)27(19-22)29(31(36)37)35-17-14-25(20-35)38-18-5-4-8-24-11-10-23-7-6-16-33-30(23)34-24;1-20-8-9-23(26-10-12-31(32,33)19-41-26)25(16-20)28(30(37)38)36-14-11-22(18-36)40-15-4-3-6-21-17-27(39-2)24-7-5-13-34-29(24)35-21;1-21-9-12-25(27-19-39-31(2,3)20-38-27)26(17-21)28(30(35)36)34-15-13-24(18-34)37-16-5-4-8-23-11-10-22-7-6-14-32-29(22)33-23;/h10-11,18-19,24,28,30H,5-9,12-17,20-21H2,1-4H3,(H,34,35)(H,37,38);9-12,19,25,28-29H,4-8,13-18,20-21H2,1-3H3,(H,33,34)(H,36,37);8-9,16-17,22,26,28H,3-7,10-15,18-19H2,1-2H3,(H,34,35)(H,37,38);9-12,17,24,27-28H,4-8,13-16,18-20H2,1-3H3,(H,32,33)(H,35,36);1H4/t24-,28?,30?;25-,28?,29?;22-,26?,28?;24-,27?,28?;/m1111./s1
InChIKeySHYLLMQQELFEMC-OAHBNQCPSA-N
MW2228.91 g/mol
LogP22.71
Rot. Bonds42

About 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane

2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane (PubChem CID 163961586) has the molecular formula C128H180F2N12O19 and a molecular weight of 2228.91 g/mol. Its IUPAC name is 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane.

Molecular Properties

Compound Name2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane
PubChem CID163961586
Molecular FormulaC128H180F2N12O19
Molecular Weight2228.91 g/mol
Exact Mass2227.35
IUPAC Name2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane
SMILESC.COc1cc(CCCCO[C@@H]2CCN(C(C(=O)O)c3cc(C)ccc3C3CCC(C)(C)CO3)C2)nc2c1CCCN2.COc1cc(CCCCO[C@@H]2CCN(C(C(=O)O)c3cc(C)ccc3C3CCC(F)(F)CO3)C2)nc2c1CCCN2.Cc1ccc(C2CCC(C)(C)CO2)c(C(C(=O)O)N2CC[C@@H](OCCCCc3ccc4c(n3)NCCC4)C2)c1.Cc1ccc(C2COC(C)(C)CO2)c(C(C(=O)O)N2CC[C@@H](OCCCCc3ccc4c(n3)NCCC4)C2)c1
InChIInChI=1S/C33H47N3O5.C32H45N3O4.C31H41F2N3O5.C31H43N3O5.CH4/c1-22-10-11-25(28-12-14-33(2,3)21-41-28)27(18-22)30(32(37)38)36-16-13-24(20-36)40-17-6-5-8-23-19-29(39-4)26-9-7-15-34-31(26)35-23;1-22-9-12-26(28-13-15-32(2,3)21-39-28)27(19-22)29(31(36)37)35-17-14-25(20-35)38-18-5-4-8-24-11-10-23-7-6-16-33-30(23)34-24;1-20-8-9-23(26-10-12-31(32,33)19-41-26)25(16-20)28(30(37)38)36-14-11-22(18-36)40-15-4-3-6-21-17-27(39-2)24-7-5-13-34-29(24)35-21;1-21-9-12-25(27-19-39-31(2,3)20-38-27)26(17-21)28(30(35)36)34-15-13-24(18-34)37-16-5-4-8-23-11-10-22-7-6-14-32-29(22)33-23;/h10-11,18-19,24,28,30H,5-9,12-17,20-21H2,1-4H3,(H,34,35)(H,37,38);9-12,19,25,28-29H,4-8,13-18,20-21H2,1-3H3,(H,33,34)(H,36,37);8-9,16-17,22,26,28H,3-7,10-15,18-19H2,1-2H3,(H,34,35)(H,37,38);9-12,17,24,27-28H,4-8,13-16,18-20H2,1-3H3,(H,32,33)(H,35,36);1H4/t24-,28?,30?;25-,28?,29?;22-,26?,28?;24-,27?,28?;/m1111./s1
InChIKeySHYLLMQQELFEMC-OAHBNQCPSA-N
XLogP22.71
TPSA363.37 Ų
H-Bond Donors8
H-Bond Acceptors27
Rotatable Bonds42
Heavy Atoms161
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002228.91
LogP ≤ 522.71
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane?
The IUPAC name of 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane (CID 163961586) is 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane.
What is the SMILES notation for 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane?
The canonical SMILES for 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane is C.COc1cc(CCCCO[C@@H]2CCN(C(C(=O)O)c3cc(C)ccc3C3CCC(C)(C)CO3)C2)nc2c1CCCN2.COc1cc(CCCCO[C@@H]2CCN(C(C(=O)O)c3cc(C)ccc3C3CCC(F)(F)CO3)C2)nc2c1CCCN2.Cc1ccc(C2CCC(C)(C)CO2)c(C(C(=O)O)N2CC[C@@H](OCCCCc3ccc4c(n3)NCCC4)C2)c1.Cc1ccc(C2COC(C)(C)CO2)c(C(C(=O)O)N2CC[C@@H](OCCCCc3ccc4c(n3)NCCC4)C2)c1.
What is the InChIKey of 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane?
The InChIKey is SHYLLMQQELFEMC-OAHBNQCPSA-N. The full InChI is InChI=1S/C33H47N3O5.C32H45N3O4.C31H41F2N3O5.C31H43N3O5.CH4/c1-22-10-11-25(28-12-14-33(2,3)21-41-28)27(18-22)30(32(37)38)36-16-13-24(20-36)40-17-6-5-8-23-19-29(39-4)26-9-7-15-34-31(26)35-23;1-22-9-12-26(28-13-15-32(2,3)21-39-28)27(19-22)29(31(36)37)35-17-14-25(20-35)38-18-5-4-8-24-11-10-23-7-6-16-33-30(23)34-24;1-20-8-9-23(26-10-12-31(32,33)19-41-26)25(16-20)28(30(37)38)36-14-11-22(18-36)40-15-4-3-6-21-17-27(39-2)24-7-5-13-34-29(24)35-21;1-21-9-12-25(27-19-39-31(2,3)20-38-27)26(17-21)28(30(35)36)34-15-13-24(18-34)37-16-5-4-8-23-11-10-22-7-6-14-32-29(22)33-23;/h10-11,18-19,24,28,30H,5-9,12-17,20-21H2,1-4H3,(H,34,35)(H,37,38);9-12,19,25,28-29H,4-8,13-18,20-21H2,1-3H3,(H,33,34)(H,36,37);8-9,16-17,22,26,28H,3-7,10-15,18-19H2,1-2H3,(H,34,35)(H,37,38);9-12,17,24,27-28H,4-8,13-16,18-20H2,1-3H3,(H,32,33)(H,35,36);1H4/t24-,28?,30?;25-,28?,29?;22-,26?,28?;24-,27?,28?;/m1111./s1.
What are the key properties of 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane?
2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane has a molecular weight of 2228.91 g/mol, XLogP of 22.71, 42 rotatable bonds, 8 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(5,5-difluorooxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyl-1,4-dioxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(4-methoxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;2-[2-(5,5-dimethyloxan-2-yl)-5-methylphenyl]-2-[(3R)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl]acetic acid;methane is sourced from PubChem (CID 163961586), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).